Hypophosphatemia in children treated with ferric carboxymaltose.

Hypophosphatemia in children treated with ferric carboxymaltose.:

Related Articles

Hypophosphatemia in children treated with ferric carboxymaltose.

Acta Paediatr. 2020 Jan 18;:

Authors: Posod A, Schaefer B, Mueller T, Zoller H, Kiechl-Kohlendorfer U

Abstract

In adults, iron-induced hypophosphatemia is an increasingly recognized adverse drug reaction of certain high-dose intravenous iron formulations, particularly ferric carboxymaltose (FCM) (1-3). Data in children are sparse, but severe hypophosphatemia has been reported in adolescents receiving FCM treatment (4). The aims of this study were to determine the incidence of hypophosphatemia in a larger pediatric collective receiving FCM for treatment of iron deficiency anemia and to evaluate potential gender differences.

PMID: 31955454 [PubMed - as supplied by publisher]